| NCT ID |
NCT04021108 |
| Title |
Phase II Study of Short Course FOLFOX Chemotherapy With Either Nivolumab or Nivolumab + Radiation in the First Line Treatment of Metastatic or Unresectable Gastroesophageal Cancers (BMS Protocol CA209-76L) |
| Recruitment |
Recruiting |
| Gender |
both |
| Phase |
Phase II |
| Variant Requirements |
Yes |
| Sponsors |
Weill Medical College of Cornell University |
| Indications |
gastric adenocarcinoma
gastroesophageal junction adenocarcinoma
gastroesophageal adenocarcinoma
|
| Therapies |
Nivolumab
Fluorouracil + Leucovorin + Nivolumab + Oxaliplatin
|
| Age Groups: |
adult
senior
|
CKB BOOST